AUTHOR SUMMARY
Ligand-gated ion channels play an important role in fast electrochemical signaling in the brain. Pentameric ligand-gated ion channels are activated by specific neurotransmitters (ligands), including acetylcholine (ACh), serotonin (5-HT), glycine (Gly), and γ-aminobutyric acid (GABA A/C ). Different receptors contain an extracellular domain that specifically recognizes one of these neurotransmitters and opens a transmembrane channel upon ligand binding. The GABA A/C and Gly receptors selectively transport chloride ions, which hyperpolarize the cell membrane and reduce electrical excitability. Here, we showed that a bacterial receptor, ELIC, is similarly activated by GABA and is modulated by therapeutically important psychoactive drugs, benzodiazepines. These findings reveal aspects of the mechanism of action of mammalian neurotransmitter signaling. GABA A receptors serve as a target for a therapeutically important class of psychoactive drugs, namely, benzodiazepines, which are widely prescribed because of their anxiolytic, anticonvulsant, muscle relaxant, and sedative hypnotic effects (1) . Benzodiazepines, such as diazepam (Valium), bind to the GABA A receptor at a site that is separate (allosteric) from the site (orthosteric) for the agonist GABA. Benzodiazepines derive their effects from a fundamental molecular property, which is to modulate channel opening when GABA is bound to the receptor. This action of benzodiazepines, positive allosteric modulation, causes a reduction of electrical excitability in the central nervous system, ultimately inducing sedation, anxiolysis, and sleep.
The molecular interactions required for recognition of GABA and benzodiazepines at their respective receptor-binding sites have been studied extensively using various approaches, including photo-affinity labeling and mutagenesis experiments. However, mechanistic details of their molecular recognition are still unclear. One major reason is that structural data for this therapeutically important class of receptors is lacking.
Here, we report that a recently identified bacterial ligandgated ion channel, ELIC, is activated by GABA and modulated by certain benzodiazepines with effects that are similar to human GABA A receptors. Similar to recent results published by Zimmermann and Dutzler (2), ELIC was found to be activated by relatively high concentrations of GABA. We determined the X-ray crystal structure of ELIC in complex with GABA, which reveals important features of agonist recognition. For example, the ligand-binding site is formed by highly conserved aromatic residues, which form an electron-rich environment that stabilizes the cationic amino moiety of GABA. To probe the importance of such cation-π interactions, we introduced nonnaturally occurring amino acid residues into ELIC and determined the affinity of GABA for each derivative. A serial decrease in agonist potency with increasing fluorination is indicative of a cation-π interaction. We observed a clear correlation between agonist potency and the cation-π-binding ability of phenylalanine derivatives incorporated into two positions of the binding site, namely, loop B and C aromatics. This result is consistent with the GABA-binding conformation in the crystal structure, which places the amino moiety almost equidistant between the loop B and C aromatic residues in the binding pocket.
Next, we determined crystal structures of ELIC in complex with different benzodiazepine-site ligands, namely, flurazepam, bromo-flurazepam, and zopiclone; zopiclone is a more recently developed nonbenzodiazepine hypnotic. We observe that, depending on their concentrations, benzodiazepines occupy two possible sites on ELIC (Fig. P1) . We discovered an intrasubunit site adjacent to the GABA-recognition site, but it faces the channel vestibule. Using cysteine-scanning mutagenesis, we demonstrated that this site is involved in the potentiating effects of flurazepam on ELIC. A second intersubunit site partially overlaps the GABA site and likely corresponds to a low-affinity benzodiazepine-binding site in GABA A receptors that mediate the inhibitory effects of the benzodiazepine flurazepam. The existence of multiple binding sites for GABA and benzodiazepines further substantiates a multisite model of allosteric modulation in this family of channels. The discovery of an intrasubunit benzodiazepine site facing the vestibule could help in understanding unexplained actions of benzodiazepines on GABA A receptors. However, further studies are warranted to investigate a possible functional role of the intrasubunit site in human GABA A receptors.
Our present study offers a structural view of how GABA and benzodiazepines are recognized at multiple allosteric binding sites; this structure helps explain the multisite modulation in the class of pentameric ligand-gated ion channels.
